Mike Zaranek - 28 Apr 2023 Form 4 Insider Report for Science 37 Holdings, Inc.

Role
Chief Financial Officer
Signature
/s/ Christine Pellizzari, Attorney-in-Fact for Mike Zaranek
Issuer symbol
N/A
Transactions as of
28 Apr 2023
Net transactions value
$0
Form type
4
Filing time
02 May 2023, 16:22:13 UTC
Previous filing
16 Aug 2022
Next filing
15 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SNCE Common Stock Award +444,283 444,283 28 Apr 2023 Direct F1, F2, F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SNCE Stock Option Disposed to Issuer -457,466 -100% 0 28 Apr 2023 Common Stock 457,466 $9.06 Direct F1, F5
transaction SNCE Stock Option Disposed to Issuer -185,897 -100% 0 28 Apr 2023 Common Stock 185,897 $11.47 Direct F2
transaction SNCE Stock Option Disposed to Issuer -467,351 -100% 0 28 Apr 2023 Common Stock 467,351 $10.05 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On April 28, 2023, the issuer cancelled, pursuant to the issuer's option exchange program, options to purchase 457,466 shares of common stock of the issuer and in exchange issued to the reporting person 182,985 restricted stock units, each of which represents a contingent right to receive one share of the issuer's common stock.
F2 On April 28, 2023, the issuer cancelled, pursuant to the issuer's option exchange program, options to purchase 185,897 shares of common stock of the issuer and in exchange issued to the reporting person 74,358 restricted stock units, each of which represents a contingent right to receive one share of the issuer's common stock.
F3 On April 28, 2023, the issuer cancelled, pursuant to the issuer's option exchange program, options to purchase 467,351 shares of common stock of the issuer and in exchange issued to the reporting person 186,940 restricted stock units, each of which represents a contingent right to receive one share of the issuer's common stock.
F4 Includes 444,283 restricted stock units, which will vest in three equal annual installments beginning on April 28, 2024, subject to continued employment.
F5 The total amount has been adjusted to add 11 derivative securities that were not previously included due to a rounding error.